Molecular mechanisms of colorectal carcinogenesis

Molecular Pathogenesis of Colorectal Cancer

Volumn , Issue , 2013, Pages 25-65

  Roper, Jatin ^a   Hung, Kenneth E ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Chromosomal instability; Colorectal cancer; Microsatellite instability; Mouse models; Serrated pathway

Indexed keywords

EID: 84929583628     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-8412-7_2     Document Type: Chapter

References (270)

1. Ahrendt SA, Decker PA, Doffek K et al (2000) Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer. Cancer Res 60(9):2488-2491
2. Akhoondi S, Sun D, von der Lehr N et al (2007) FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 67(19):9006-9012
3. Albertini RJ, Nicklas JA, O'Neill JP, Robison SH (1990) In vivo somatic mutations in humans: measurement and analysis. Annu Rev Genet 24:305-326
4. Aoki K, Aoki M, Sugai M et al (2007) Chromosomal instability by β-catenin/TCF transcription in APC or β-catenin mutant cells. Oncogene 26(24):3511-3520
5. Arain MA, Sawhney M, Sheikh S et al (2010) CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 105(5):1189-1195
6. Arber N, Eagle CJ, Spicak J et al (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355(9):885-895
7. Barbie DA, Tamayo P, Boehm JS et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462(7269):108-112
8. Bardelli A, Cahill DP, Lederer G et al (2001) Carcinogen-specifi c induction of genetic instability. Proc Natl Acad Sci U S A 98(10):5770-5775
9. Bardi G, Parada LA, Bomme L et al (1997) Cytogenetic comparisons of synchronous carcinomas and polyps in patients with colorectal cancer. Br J Cancer 76(6):765-769
10. Baron JA, Sandler RS, Bresalier RS et al (2006) A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131(6):1674-1682
11. Bassing CH, Suh H, Ferguson DO et al (2003) Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114(3):359-370
12. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L (2009) Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150(1):1-8
13. Benatti P, Gafà R, Barana D et al (2005) Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res 11(23):8332-8340
14. Bertagnolli MM, Eagle CJ, Zauber AG et al (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355(9):873-884
15. Bertagnolli MM, Niedzwiecki D, Compton CC et al (2009) Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fl uorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J Clin Oncol 27(11):1814-1821
16. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M (1994) Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci U S A 91(14):6319-6323
17. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321(6067):209-213
18. Blake C, Tsao J-L, Wu A, Shibata D (2001) Stepwise deletions of PolyA sequences in mismatch repair-defi cient colorectal cancers. Am J Pathol 158(5):1867-1870
19. Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138(6):2073-2087.e3
20. Boland CR, Thibodeau SN, Hamilton SR et al (1998) A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58(22):5248-5257
21. Bomme L, Bardi G, Pandis N, Fenger C, Kronborg O, Heim S (1994) Clonal karyotypic abnormalities in colorectal adenomas: clues to the early genetic events in the adenoma-carcinoma sequence. Genes Chromosomes Cancer 10(3):190-196
22. Bondi J, Husdal A, Bukholm G, Nesland JM, Bakka A, Bukholm IRK (2005) Expression and gene amplifi cation of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. J Clin Pathol 58(5):509-514
23. Boparai KS, Dekker E, Van Eeden S et al (2008) Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 135(6):2014-2018
24. Boparai KS, Mathus-Vliegen EMH, Koornstra JJ et al (2010) Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut 59(8):1094-1100
25. Boveri T (2008) Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci 121(Suppl 1):1-84
26. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U (2010) Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102(2):89-95
27. Brentnall TA, Crispin DA, Bronner MP et al (1996) Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 56(6):1237-1240
28. Bresalier RS, Sandler RS, Quan H et al (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352(11):1092-1102
29. Bressler B, Paszat LF, Vinden C, Li C, He J, Rabeneck L (2004) Colonoscopic miss rates for rightsided colon cancer: a population-based analysis. Gastroenterology 127(2):452-456
30. Buchanan DD, Sweet K, Drini M et al (2010) Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis 25(6):703-712
31. Campisi J (2005) Suppressing cancer: the importance of being senescent. Science 309(5736):886-887
32. Camps J, Nguyen QT, Padilla-Nash HM et al (2009) Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer 48(11):1002-1017
33. Cardoso J, Molenaar L, De Menezes RX et al (2006) Chromosomal instability in MYH- and APCmutant adenomatous polyps. Cancer Res 66(5):2514-2519
34. Carragher LAS, Snell KR, Giblett SM et al (2010) V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med 2(11):458-471
35. Castets M, Broutier L, Molin Y et al (2011) DCC constrains tumour progression via its dependence receptor activity. Nature 482(7386):534-537 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22158121
36. Castillo A, Morse HC III, Godfrey VL, Naeem R, Justice MJ (2007) Overexpression of Eg5 causes genomic instability and tumor formation in mice. Cancer Res 67(21):10138-10147
37. Celeste A, Difi lippantonio S, Difi lippantonio MJ et al (2003) H2AX haploinsuffi ciency modifi es genomic stability and tumor susceptibility. Cell 114(3):371-383
38. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S (1995) Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55(12):2533-2536
39. Chalhoub N, Baker SJ (2009) PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4:127-150
40. Chan AT, Giovannucci EL (2010) Primary prevention of colorectal cancer. Gastroenterology 138(6):2029-2043.e10
41. Chan AO-O, Issa J-PJ, Morris JS, Hamilton SR, Rashid A (2002) Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 160(2):529-536
42. Chang CL, Marra G, Chauhan DP et al (2002) Oxidative stress inactivates the human DNA mismatch repair system. Am J Physiol Cell Physiol 283(1):C148-C154
43. Chen Z, Trotman LC, Shaffer D et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-defi cient tumorigenesis. Nature 436(7051):725-730
44. Chirieac LR, Shen L, Catalano PJ, Issa J-P, Hamilton SR (2005) Phenotype of microsatellite-stable colorectal carcinomas with CpG island methylation. Am J Surg Pathol 29(4):429-436
45. Chow E, Lipton L, Lynch E et al (2006) Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131(1):30-39
46. Cianciulli A, Cosimelli M, Marzano R et al (2004) Genetic and pathologic signifi cance of 1p, 17p, and 18q aneusomy and the ERBB2 gene in colorectal cancer and related normal colonic mucosa. Cancer Genet Cytogenet 151(1):52-59
47. Cole BF, Logan RF, Halabi S et al (2009) Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101(4):256-266
48. Cottrell S, Bicknell D, Kaklamanis L, Bodmer WF (1992) Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas. Lancet 340(8820):626-630
49. Cuilliere-Dartigues P, El-Bchiri J, Krimi A et al (2006) TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription. Oncogene 25(32):4441-4448
50. Curfman GD, Morrissey S, Drazen JM (2005) Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis", N Engl J Med 2000;343:1520-8. N Engl J Med 353(26):2813-2814
51. Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949-954
52. de Vogel S, Weijenberg MP, Herman JG et al (2009) MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol 20(7):1216-1222
53. de Vos tot Nederveen Cappel WH, Meulenbeld HJ, Kleibeuker JH et al (2004) Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. Int J Cancer 109(3):468-471
54. Des Guetz G, Lecaille C, Mariani P et al (2010) Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX. Anticancer Res 30(10):4297-4301
55. Di Vinci A, Infusini E, Peveri C, Risio M, Rossini FP, Giaretti W (1996) Deletions at chromosome 1p by fl uorescence in situ hybridization are an early event in human colorectal tumorigenesis. Gastroenterology 111(1):102-107
56. Diep CB, Thorstensen L, Meling GI, Skovlund E, Rognum TO, Lothe RA (2003) Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients. J Clin Oncol 21(5):820-829
57. Dotan E, Meropol NJ, Zhu F et al (2012) Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer. Br J Cancer 106(4):748-755 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22240781
58. Duesberg P, Fabarius A, Hehlmann R (2004) Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 56(2):65-81
59. East JE, Saunders BP, Jass JR (2008) Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classifi cation, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am 37(1):25-46
60. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107(4):1183-1188
61. Eilers M, Eisenman RN (2008) Myc's broad reach. Genes Dev 22(20):2755-2766
62. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B (2000) Association of tumour site and sex with survival benefi t from adjuvant chemotherapy in colorectal cancer. Lancet 355(9217):1745-1750
63. Engelhardt M, Drullinsky P, Guillem J, Moore MAS (1997) Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 3(11):1931-1941
64. English DR, Young JP, Simpson JA et al (2008) Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev 17(7):1774-1780
65. Esteller M, Sparks A, Toyota M et al (2000) Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60(16):4366-4371
66. Fallik D, Borrini F, Boige V et al (2003) Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res 63(18):5738-5744
67. Farrar WD, Sawhney MS, Nelson DB, Lederle FA, Bond JH (2006) Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 4(10):1259-1264
68. Fazeli A, Dickinson SL, Hermiston ML et al (1997) Phenotype of mice lacking functional deleted in colorectal cancer (Dec) gene. Nature 386(6627):796-804
69. Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479-507
70. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759-767
71. Fearon ER, Cho KR, Nigro JM et al (1990) Identifi cation of a chromosome 18q gene that is altered in colorectal cancers. Science 247(4938):49-56
72. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48(5):1159-1161
73. Ferrández A, Samowitz W, DiSario JA, Burt RW (2004) Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 99(10):2012-2018
74. Firestein R, Hahn WC (2009) Revving the throttle on an oncogene: CDK8 takes the driver seat. Cancer Res 69(20):7899-7901
75. Firestein R, Bass AJ, Kim SY et al (2008) CDK8 is a colorectal cancer oncogene that regulates [bgr]-catenin activity. Nature 455(7212):547-551
76. Firestein R, Shima K, Nosho K et al (2010) CDK8 expression in 470 colorectal cancers in relation to β-catenin activation, other molecular alterations and patient survival. Int J Cancer 126(12):2863-2873
77. Fodde R, Kuipers J, Rosenberg C et al (2001) Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3(4):433-438
78. Fujita K, Yamamoto H, Matsumoto T et al (2011) Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol 35(2):295-304
79. Ganem NJ, Godinho SA, Pellman D (2009) A mechanism linking extra centrosomes to chromosomal instability. Nature 460(7252):278-282
80. Garcia-Albeniz X, Chan AT (2011) Aspirin for the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol 25(4-5):461-472
81. Gasche C, Chang CL, Rhees J, Goel A, Boland CR (2001) Oxidative stress increases frameshift mutations in human colorectal cancer cells. Cancer Res 61(20):7444-7448
82. Gertler R, Rosenberg R, Stricker D et al (2004) Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol 22(10):1807-1814
83. Glazer E, Golla V, Forman R, Zhu H, Levi G, Bodenheimer HC Jr (2008) Serrated adenoma is a risk factor for subsequent adenomatous polyps. Dig Dis Sci 53(8):2204-2207
84. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228(4696):187-190
85. Grady WM, Myeroff LL, Swinler SE et al (1999) Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 59(2):320-324
86. Hadjihannas MV, Brückner M, Jerchow B, Birchmeier W, Dietmaier W, Behrens J (2006) Aberrant Wnt/β-catenin signaling can induce chromosomal instability in colon cancer. Proc Natl Acad Sci U S A 103(28):10747-10752
87. Hahn E, Kraus S, Arber N (2010) Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer. Dig Dis 28(4-5):585-589
88. Haigis KM, Kendall KR, Wang Y et al (2008) Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet 40(5):600-608
89. Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851-1860
90. Hawkins NJ, Ward RL (2001) Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 93(17):1307-1313
91. Hawkins N, Norrie M, Cheong K et al (2002) CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122(5):1376-1387
92. He T-C, Sparks AB, Rago C et al (1998) Identifi cation of c-MYC as a target of the APC pathway. Science 281(5382):1509-1512
93. Herz C, Schlürmann F, Batarello D et al (2011) Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition. Mol Carcinog 51(9):696-710 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21739483
94. Hezel AF, Bardeesy N (2008) LKB1; linking cell structure and tumor suppression. Oncogene 27(55):6908-6919
95. Higuchi T, Sugihara K, Jass JR (2005) Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 47(1):32-40
96. Hiraoka S, Kato J, Fujiki S, et al (2010) The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology 139(5):1503-1510, 1510.e1-3
97. Höglund M, Gisselsson D, Hansen GB, Säll T, Mitelman F, Nilbert M (2002) Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenomacarcinoma transition. Cancer Res 62(20):5939-5946
98. Hornick JL, Odze RD (2009) Polyps of the large intestine, 2nd edn. Elsevier, Philadelphia
99. Hung KE, Maricevich MA, Richard LG et al (2010) Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc Natl Acad Sci U S A 107(4):1565-1570
100. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF (2002) Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 346(23):1781-1785
101. Infante JR, Kurzrock R, Spratlin J et al (2012) A phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors. Cancer Chemother Pharmacol 69(1):165-172
102. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363(6429):558-561
103. Iwatsuki M, Mimori K, Ishii H et al (2010) Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical signifi cance. Int J Cancer 126(8):1828-1837
104. Jani JP, Arcari J, Bernardo V et al (2010) PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy. Mol Cancer Ther 9(4):883-894
105. Jaramillo E, Tamura S, Mitomi H (2005) Endoscopic appearance of serrated adenomas in the colon. Endoscopy 37(3):254-260
106. Jass JR (2007) Classifi cation of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50(1):113-130
107. Jass JR, Iino H, Ruszkiewicz A et al (2000) Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47(1):43-49
108. Jass JR, Baker K, Zlobec I et al (2006) Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology 49(2):121-131
109. Jeevaratnam P, Cottier DS, Browett PJ, Van De Water NS, Pokos V, Jass JR (1996) Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J Pathol 179(1):20-25
110. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
111. Ji W, Hernandez R, Zhang XY et al (1997) DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res 379(1):33-41
112. Ji B-T, Weissfeld JL, Chow W-H, Huang W-Y, Schoen RE, Hayes RB (2006) Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 15(5):897-901
113. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21(2):163-167
114. Jover R, Zapater P, Castells A et al (2006) Mismatch repair status in the prediction of benefi t from adjuvant fl uorouracil chemotherapy in colorectal cancer. Gut 55(6):848-855
115. Jung B, Smith EJ, Doctolero RT et al (2006) Infl uence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer 118(10): 2509-2513
116. Jung BH, Beck SE, Cabral J et al (2007) Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin. Gastroenterology 132(2):633-644
117. Kakar S, Burgart LJ, Thibodeau SN et al (2003) Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer 97(6):1421-1427
118. Kambara T, Simms LA, Whitehall VLJ et al (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53(8):1137-1144
119. Kane MF, Loda M, Gaida GM et al (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57(5):808-811
120. Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, Näthke IS (2001) A role for the adenomatous polyposis coli protein in chromosome segregation. Nat Cell Biol 3(4):429-432
121. Karapetis CS, Khambata-Ford S, Jonker DJ et al (2008) K-ras mutations and benefi t from cetuximab in advanced colorectal cancer. N Engl J Med 359(17):1757-1765
122. Katayama H, Ota T, Jisaki F et al (1999a) Mitotic kinase expression and colorectal cancer progression. J Natl Cancer Inst 91(13):1160-1162
123. Katayama S, Shiota G, Oshimura M, Kawasaki H (1999b) Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer. J Cancer Res Clin Oncol 125(7):405-410
124. Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27(3):247-254
125. Kim GP, Colangelo LH, Wieand HS et al (2007) Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol 25(7):767-772
126. Kim MS, Lee J, Sidransky D (2010a) DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29(1):181-206
127. Kim K-M, Lee EJ, Kim Y-H, Chang DK, Odze RD (2010b) KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol 34(5):667-675
128. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87(2):159-170
129. Kirley SD, D'Apuzzo M, Lauwers GY, Graeme-Cook F, Chung DC, Zukerberg LR (2005) The cables gene on chromosome 18Q regulates colon cancer progression in vivo. Cancer Biol Ther 4(8):861-863
130. Lambert R, Kudo SE, Vieth M et al (2009) Pragmatic classifi cation of superfi cial neoplastic colorectal lesions. Gastrointest Endosc 70(6):1182-1199
131. Lammi L, Arte S, Somer M et al (2004) Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 74(5):1043-1050
132. Lanza G, Gafà R, Santini A, Maestri I, Guerzoni L, Cavazzini L (2006) Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 24(15):2359-2367
133. Leary RJ, Lin JC, Cummins J et al (2008) Integrated analysis of homozygous deletions, focal amplifi cations, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci 105(42):16224-16229
134. Lee S-H, Chang DK, Goel A et al (2003) Microsatellite instability and suppressed DNA repair enzyme expression in rheumatoid arthritis. J Immunol 170(4):2214-2220
135. Leggett B, Whitehall V (2010) Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138(6):2088-2100
136. Leggett BA, Cornwell M, Thomas LR et al (1997) Characteristics of metachronous colorectal carcinoma occurring despite colonoscopic surveillance. Dis Colon Rectum 40(5):603-608
137. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J (2001) Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 25(2):177-184
138. Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386(6625):623-627
139. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396(6712):643-649
140. Leslie A, Carey FA, Pratt NR, Steele RJC (2002) The colorectal adenoma-carcinoma sequence. Br J Surg 89(7):845-860
141. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88(3):323-331
142. Li D, Jin C, McCulloch C et al (2009) Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol 104(3):695-702
143. Li H-T, Lu Y-Y, An Y-X, Wang X, Zhao Q-C (2011) KRAS, BRAF and PIK3CA mutations in human colorectal cancer: relationship with metastatic colorectal cancer. Oncol Rep 25(6):1691- 1697, Available from: http://www.ncbi.nlm.nih.gov/pubmed/21424126
144. Loeb LA, Loeb KR, Anderson JP (2003) Multiple mutations and cancer. Proc Natl Acad Sci U S A 100(3):776-781
145. Longacre TA, Fenoglio-Preiser CM (1990) Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 14(6):524-537
146. Lothe RA, Andersen SN, Hofstad B et al (1995) Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes Cancer 14(3):182-188
147. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348(10):919-932
148. Mäkinen MJ, George SM, Jernvall P, Mäkelä J, Vihko P, Karttunen TJ (2001) Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. J Pathol 193(3):286-294
149. Malumbres M, Barbacid M (2003) RAS oncogenes: the fi rst 30 years. Nat Rev Cancer 3(6):459-465
150. Mann B, Gelos M, Siedow A et al (1999) Target genes of β-catenin-T cell-factor/lymphoidenhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 96(4):1603-1608
151. Markowitz S, Wang J, Myeroff L et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268(5215):1336-1338
152. Mehlen P, Fearon ER (2004) Role of the dependence receptor DCC in colorectal cancer pathogenesis. J Clin Oncol 22(16):3420-3428
153. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395(6704):801-804
154. Merg A, Howe JR (2004) Genetic conditions associated with intestinal juvenile polyps. Am J Med Genet C Semin Med Genet 129C(1):44-55
155. Meylan E, Dooley AL, Feldser DM et al (2009) Requirement for NF-B signalling in a mouse model of lung adenocarcinoma. Nature 462(7269):104-107
156. Minoo P, Jass JR (2006) Senescence and serration: a new twist to an old tale. J Pathol 210(2):137-140
157. Minoo P, Baker K, Goswami R et al (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55(10):1467-1474
158. Mirabelli-Primdahl L, Gryfe R, Kim H et al (1999) Beta-catenin mutations are specifi c for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59(14):3346-3351
159. Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54(11):3011-3020
160. Miyaki M, Iijima T, Kimura J et al (1999) Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 59(18):4506-4509
161. Miyoshi Y, Nagase H, Ando H et al (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1(4):229-233
162. Morson B (1974) President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med 67(6 Pt 1):451-457
163. Munro AJ, Lain S, Lane DP (2005) P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer 92(3):434-444
164. Nakamura K-I, Furugori E, Esaki Y et al (2000) Correlation of telomere lengths in normal and cancers tissue in the large bowel. Cancer Lett 158(2):179-184
165. Negrini S, Gorgoulis VG, Halazonetis TD (2010) Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11(3):220-228
166. Nowak MA, Komarova NL, Sengupta A et al (2002) The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A 99(25):16226-16231
167. O'Brien MJ (2007) Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 36(4):947-968
168. viii O'Brien MJ, Yang S, Clebanoff JL et al (2004) Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 28(4):423-434
169. O'Brien MJ, Yang S, Mack C et al (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30(12):1491-1501
170. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS (2006a) CpG island methylator phenotypelow (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8(5):582-588
171. Ogino S, Odze RD, Kawasaki T et al (2006b) Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol 30(9):1175-1183
172. Ogino S, Kawasaki T, Kirkner GJ, Suemoto Y, Meyerhardt JA, Fuchs CS (2007) Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype- low (CIMP-low) in colorectal cancer. Gut 56(11):1564-1571
173. Ogino S, Nosho K, Kirkner GJ et al (2009a) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58(1):90-96
174. Ogino S, Nosho K, Irahara N et al (2009b) Prognostic signifi cance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. J Clin Oncol 27(27):4591-4598
175. Ogino S, Nosho K, Irahara N et al (2009c) Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 15(20):6412-6420
176. Ogino S, Shima K, Meyerhardt J et al (2011) Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res 18(3):890- 900, Available from: http://www.ncbi.nlm.nih.gov/pubmed/22147942
177. Oshima M, Murai N, Kargman S et al (2001) Chemoprevention of intestinal polyposis in the ApcΔ716 mouse by rofecoxib, a specifi c cyclooxygenase-2 inhibitor. Cancer Res 61(4):1733-1740
178. Park DY, Sakamoto H, Kirley SD et al (2007) The cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. Am J Pathol 171(5):1509-1519
179. Peddibhotla S, Lam MH, Gonzalez-Rimbau M, Rosen JM (2009) The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis. Proc Natl Acad Sci U S A 106(13):5159-5164
180. Pérez R, Lasa A, Toro DH, Cruz-Correa M, Martinez-Souss J (2010) Relationship between sporadic hyperplastic polyps and colorectal neoplasia in Hispanic veterans. P R Health Sci J 29(4):372-376
181. Phillips SM, Banerjea A, Feakins R, Li SR, Bustin SA, Dorudi S (2004) Tumour-infi ltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg 91(4):469-475
182. Pino MS, Chung DC (2010) The chromosomal instability pathway in colon cancer. Gastroenterology 138(6):2059-2072
183. Plentz RR, Wiemann SU, Flemming P et al (2003) Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer. Gut 52(9):1304-1307
184. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23(3):609-618
185. Powell SM, Zilz N, Beazer-Barclay Y et al (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359(6392):235-237
186. Pretlow TP, Pretlow TG (2005) Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta 1756(2):83-96
187. Pruitt K, Der CJ (2001) Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett 171(1):1-10
188. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418(6901):934
189. Rajagopalan H, Jallepalli PV, Rago C et al (2004) Inactivation of hCDC4 can cause chromosomal instability. Nature 428(6978):77-81
190. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR (2000) Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 119(2):323-332
191. Ribic CM, Sargent DJ, Moore MJ et al (2003) Tumor microsatellite-instability status as a predictor of benefi t from fl uorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349(3):247-257
192. Roper J, Richardson MP, Wang WV et al (2011) The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer. PLoS One 6(9):e25132
193. Roschke AV, Glebov OK, Lababidi S, Gehlhaus KS, Weinstein JN, Kirsch IR (2008) Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance. Neoplasia 10(11):1222-1230
194. Rubio CA, Stemme S, Jaramillo E, Lindblom A (2006) Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 38(3):266-270
195. Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ (2011) Nonsteroidal anti-infl ammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 106(7):1340-1350
196. Rudolph KL, Millard M, Bosenberg MW, DePinho RA (2001) Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 28(2):155-159
197. Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N (2005) The TP53 colorectal cancer international collaborative study on the prognostic and predictive signifi cance of p53 mutation: infl uence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 23(30):7518-7528
198. Samowitz WS, Albertsen H, Herrick J et al (2005a) Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129(3):837-845
199. Samowitz WS, Sweeney C, Herrick J et al (2005b) Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 65(14):6063-6069
200. Samowitz WS, Albertsen H, Sweeney C et al (2006) Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 98(23):1731-1738
201. Samuels Y, Wang Z, Bardelli A et al (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304(5670):554
202. Samuels Y, Diaz LA, Schmidt-Kittler O et al (2005) Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7(6):561-573
203. Sandmeier D, Benhattar J, Martin P, Bouzourene H (2009) Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps. Histopathology 55(2):206-213
204. Sawhney MS, Farrar WD, Gudiseva S et al (2006) Microsatellite instability in interval colon cancers. Gastroenterology 131(6):1700-1705
205. Schöffski P, Awada A, Dumez H et al (2012) A phase I, dose-escalation study of the novel Pololike kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours. Eur J Cancer 48(2):179-186
206. Schreiner MA, Weiss DG, Lieberman DA (2010) Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology 139(5):1497-1502
207. Shia J (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. J Mol Diagn 10(4):293-300
208. Shih I-M, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B (2001) Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61(3):818-822
209. Shima K, Morikawa T, Yamauchi M et al (2011) TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers. PLoS One 6(9):e25062
210. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T (1993) Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260(5104):85-88
211. Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W (2008) Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 167(9):1050-1058
212. Sinicrope FA, Rego RL, Halling KC et al (2006) Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 131(3):729-737
213. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP (2005) Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 124(3):380-391
214. Souglakos J, Philips J, Wang R et al (2009) Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer 101(3):465-472
215. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998) Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 58(6):1130-1134
216. Spring KJ, Zhao ZZ, Karamatic R et al (2006) High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131(5):1400-1407
217. Stoler DL, Chen N, Basik M et al (1999) The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A 96(26):15121-15126
218. Storojeva I, Boulay J-L, Heinimann K et al (2005) Prognostic and predictive relevance of microsatellite instability in colorectal cancer. Oncol Rep 14(1):241-249
219. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL (1987) Natural history of untreated colonic polyps. Gastroenterology 93(5):1009-1013
220. Suzuki H, Harpaz N, Tarmin L et al (1994) Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res 54(18):4841-4844
221. Suzuki H, Igarashi S, Nojima M et al (2010) IGFBP7 is a p53-responsive gene specifi cally silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis 31(3):342-349
222. Takagi Y, Kohmura H, Futamura M et al (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111(5):1369-1372
223. Takagi Y, Koumura H, Futamura M et al (1998) Somatic alterations of the SMAD-2 gene in human colorectal cancers. Br J Cancer 78(9):1152-1155
224. Takagi S, Kinouchi Y, Hiwatashi N et al (1999) Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas. Cancer 86(8):1431-1436
225. Takahashi T, Sano B, Nagata T et al (2003) Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci 94(2):148-152
226. Takayama T, Katsuki S, Takahashi Y et al (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339(18):1277-1284
227. Tan Y, Sangfelt O, Spruck C (2008) The Fbxw7/hCdc4 tumor suppressor in human cancer. Cancer Lett 271(1):1-12
228. Tanaka K, Yanoshita R, Konishi M et al (1993) Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene 8(8):2253-2258
229. Tateyama H, Li W, Takahashi E, Miura Y, Sugiura H, Eimoto T (2002) Apoptosis index and apoptosis- related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition of apoptosis. Am J Surg Pathol 26(2):249-256
230. Tatsumoto N, Hiyama E, Murakami Y et al (2000) High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res 6(7):2696-2701
231. Taylor SS, McKeon F (1997) Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89(5):727-735
232. Tedesco FJ, Hendrix JC, Pickens CA, Brady PG, Mills LR (1982) Diminutive polyps: histopathology, spatial distribution, and clinical signifi cance. Gastrointest Endosc 28(1):1-5
233. Thiagalingam S, Laken S, Willson JKV et al (2001) Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A 98(5):2698-2702
234. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260(5109):816-819
235. Tol J, Nagtegaal ID, Punt CJA (2009) BRAF mutation in metastatic colorectal cancer. N Engl J Med 361(1):98-99
236. Torlakovic E, Snover DC (1996) Serrated adenomatous polyposis in humans. Gastroenterology 110(3):748-755
237. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM (2003) Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27(1):65-81
238. Torlakovic EE, Gomez JD, Driman DK et al (2008) Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 32(1):21-29
239. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96(15):8681-8686
240. Tran B, Kopetz S, Tie J et al (2011) Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer 117(20):4623- 4632, Available from: http://www.ncbi.nlm.nih.gov/pubmed/21456008
241. Van Cutsem E, Köhne C-H, Láng I et al (2011) Cetuximab plus irinotecan, fl uorouracil, and leucovorin as fi rst-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol 29(15):2011-2019
242. Vasen HFA (2005) Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer 4(3):219-225
243. Vasen HFA, Mecklin J-P, Meera Khan P, Lynch HT (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34(5):424-425
244. Vasen HFA, Watson P, Mecklin J-P, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116(6):1453-1456
245. Veigl ML, Kasturi L, Olechnowicz J et al (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci U S A 95(15):8698-8702
246. Vogelstein B, Fearon ER, Hamilton SR et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319(9):525-532
247. Vogelstein B, Fearon E, Kern S et al (1989) Allelotype of colorectal carcinomas. Science 244(4901):207-211
248. Vogelstein B, Lane D, Levine AJ (2000) Surfi ng the p53 network. Nature 408(6810):307-310
249. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR (2008) Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132(3):363-374
250. Wallace K, Grau MV, Ahnen D et al (2009) The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 18(8):2310-2317
251. Wang L, Cunningham JM, Winters JL et al (2003) BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res 63(17):5209-5212
252. Wang Z, Cummins JM, Shen D et al (2004) Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res 64(9):2998-3001
253. Ward R, Meagher A, Tomlinson I et al (2001) Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 48(6):821-829
254. Ward RL, Cheong K, Ku S-L, Meagher A, O'Connor T, Hawkins NJ (2003) Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol 21(20):3729-3736
255. Warthin A (1913) Heredity with reference to carcinoma-as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895-1913. Arch Intern Med 12(5):546-555
256. Weisenberger DJ, Siegmund KD, Campan M et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38(7):787-793
257. Whitehall VL, Walsh MD, Young J, Leggett BA, Jass JR (2001) Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 61(3):827-830
258. Winawer SJ, Zauber AG, Ho MN et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329(27):1977-1981
259. Wood LD, Parsons DW, Jones S et al (2007) The genomic landscapes of human breast and colorectal cancers. Science 318(5853):1108-1113
260. Wu JM, Montgomery EA, Iacobuzio-Donahue CA (2008) Frequent beta-catenin nuclear labeling in sessile serrated polyps of the colorectum with neoplastic potential. Am J Clin Pathol 129(3):416-423
261. Wynter CVA, Walsh MD, Higuchi T, Leggett BA, Young J, Jass JR (2004) Methylation patterns defi ne two types of hyperplastic polyp associated with colorectal cancer. Gut 53(4):573-580
262. Yachida S, Mudali S, Martin SA, Montgomery EA, Iacobuzio-Donahue CA (2009) Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation. Am J Surg Pathol 33(12):1823-1832
263. Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ (2004) BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol 28(11):1452-1459
264. Young J, Jass JR (2006) The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 15(10): 1778-1784
265. Young J, Jenkins M, Parry S et al (2007) Serrated pathway colorectal cancer in the population: genetic consideration. Gut 56(10):1453-1459
266. Yuen ST, Davies H, Chan TL et al (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62(22):6451-6455
267. Yun J, Rago C, Cheong I et al (2009) Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325(5947):1555-1559
268. Zha S, Sekiguchi J, Brush JW, Bassing CH, Alt FW (2008) Complementary functions of ATM and H2AX in development and suppression of genomic instability. Proc Natl Acad Sci U S A 105(27):9302-9306
269. Zhang L (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J Mol Diagn 10(4):301-307
270. Zhou W, Goodman SN, Galizia G et al (2002) Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet 359(9302):219-225